Barchart.com
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Regenxbio Inc (RGNX)

Regenxbio Inc (RGNX)
8.95 x 1 9.40 x 5
Post-market by (Cboe BZX)
9.20 +0.33 (+3.72%) 04/24/25 [NASDAQ]
8.95 x 1 9.40 x 5
Post-market 9.20 unch (unch) 19:42 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Regenxbio: Q4 Earnings Snapshot AP - Thu Mar 13, 3:25PM CDT

Regenxbio: Q4 Earnings Snapshot

RGNX : 9.20 (+3.72%)
Regenxbio: Q3 Earnings Snapshot AP - Wed Nov 6, 2024

Regenxbio: Q3 Earnings Snapshot

RGNX : 9.20 (+3.72%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth FinancialNewsMedia - Wed Sep 4, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

SBFM : 1.5500 (+5.44%)
RGNX : 9.20 (+3.72%)
NVAX : 7.07 (-5.35%)
ABBV : 180.37 (+1.88%)
BNTX : 120.54 (+4.97%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth GlobeNewswire - Wed Sep 4, 2024

SBFM : 1.5500 (+5.44%)
RGNX : 9.20 (+3.72%)
NVAX : 7.07 (-5.35%)
ABBV : 180.37 (+1.88%)
BNTX : 120.54 (+4.97%)
Regenxbio: Q2 Earnings Snapshot AP - Thu Aug 1, 2024

Regenxbio: Q2 Earnings Snapshot

RGNX : 9.20 (+3.72%)
Regenxbio: Q1 Earnings Snapshot AP - Wed May 8, 2024

Regenxbio: Q1 Earnings Snapshot

RGNX : 9.20 (+3.72%)
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling? Motley Fool - Wed Mar 13, 2024

The threat is still emerging, but it could be significant.

SRPT : 61.76 (+3.82%)
RGNX : 9.20 (+3.72%)
Regenxbio: Q4 Earnings Snapshot AP - Tue Feb 27, 2024

Regenxbio: Q4 Earnings Snapshot

RGNX : 9.20 (+3.72%)
Regenxbio: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Regenxbio: Q3 Earnings Snapshot

RGNX : 9.20 (+3.72%)
REGENXBIO to Participate in the Jefferies CNS/Neuro Summit PR Newswire - Thu Oct 5, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Jefferies CNS/Neuro Summit on Thursday, October 12, 2023. Jefferies...

RGNX : 9.20 (+3.72%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - 1 hour ago
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot